Analysis of Risk Factors for Kasabach Merritt Phenomenom in Children With Kaposiform Hemangioendothelioma

Chen Chen1, Hanlei Yan2, Wei Yao1

  • 1Department of Pediatric Surgery, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.

PubMed
Abstract

Insights

Early onset (≤1 month), deep, large (>60 mm), non-extremity Kaposiiform hemangioendothelioma (KHE) lesions significantly increase Kasabach-Merritt phenomenon (KMP) risk in children. Identifying these factors aids early KMP recognition and intervention.

Area of Science:

  • Pediatric Oncology
  • Vascular Anomalies
  • Hematology

Background:

  • Kaposiform hemangioendothelioma (KHE) is a rare vascular tumor in children.
  • Kasabach-Merritt phenomenon (KMP) is a serious complication of KHE, involving thrombocytopenia and coagulopathy.
  • Understanding KHE clinical attributes is crucial for identifying KMP risk factors.

Purpose of the Study:

  • To analyze clinical features of KHE patients.
  • To identify risk factors associated with KMP development in KHE.
  • To develop a predictive model for KMP in pediatric KHE.

Main Methods:

  • Retrospective analysis of 96 pediatric KHE cases (2013-2021).
  • Comparison between KHE with KMP (n=62) and KHE without KMP (n=34) groups.
  • Univariate and binary logistic regression analyses were performed to identify risk factors.

Main Results:

  • Independent risk factors for KMP in KHE include: onset age ≤1 month (51x risk), non-extremity lesion site (21x risk), deeper lesions (5x risk), and lesion size >60 mm (17x risk).
  • A predictive model with 82.9% accuracy was developed: Logit(P) = 3.937*(age) + 1.558*(depth) + 3.021*(site) + 2.832*(size).
  • A scoring system indicated KMP likelihood if the score exceeded 72.5.

Conclusions:

  • Early age of onset, deeper and larger lesions, and non-extremity locations are significant independent risk factors for KMP in pediatric KHE.
  • The presence of multiple risk factors increases KMP likelihood.
  • Early identification of these factors enables timely therapeutic intervention for KMP in KHE patients.